← Leaderboards
Emily S Day
Northwestern University
$5,404,299
Attributed
$5,404,299
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $838.1K · FY2012–25$1M$750K$500K$250K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,404,299 · 5
By mechanism
R35$3,193,269 · 2
R01$1,733,424 · 1
R21$430,063 · 1
F32$47,543 · 1
Top collaborators
No co-investigators on record.
Most similar at Northwestern University
Same institution · by research overlap
- Debiao Li$36,112,049
- Casey Adams$112,432
- Vadim Backman$34,873,053
- Joseph T Walsh$1,892,149
- Sui Huang$7,725,088
Others in their field
Top investigators on “Nanoparticle”
- David Heimbrook · Leidos Biomedical Research, Inc.$67,480,937
- Ralph Weissleder · Massachusetts General Hospital$52,944,531
- Robert J Hamers · University Of Wisconsin-Madison$40,936,500
- Gang Bao · Georgia Institute Of Technology$28,866,343
- Barton F Haynes · Duke University$28,645,614
- Bala Raja · Luminostics, Inc.$28,624,460
Research focus
NanoparticleCellsBindingBiologicalAntibodiesGenesFutureGene ExpressionProteinsQuality Of LifeMediatingReceptorTissuesMalignant Breast NeoplasmNanocarrierMalignant NeoplasmsSafetyPenetrationNanoparticle DeliveryBiological SystemsDisease ProgressionNanomedicineGoldIn Vitro
Grant awards (16)
Photoacoustic imaging of endometriosis with nanoparticle contrast agents$430,063
R21 · FY2025 · HD · contact PI
Probing nano/bio interactions to understand and overcome biological barriers limiting nanomedicine$408,005
R35 · FY2025 · GM · contact PI
Probing nano/bio interactions to understand and overcome biological barriers limiting nanomedicine$408,005
R35 · FY2024 · GM · contact PI
Probing nano/bio interactions to understand and overcome biological barriers limiting nanomedicine$408,005
R35 · FY2023 · GM · contact PI
Multifunctional siRNA/antibody nanocarriers to treat metastatic triple-negative breast cancer$342,055
R01 · FY2023 · CA · contact PI
Multifunctional siRNA/antibody nanocarriers to treat metastatic triple-negative breast cancer$342,278
R01 · FY2022 · CA · contact PI
Multifunctional siRNA/antibody nanocarriers to treat metastatic triple-negative breast cancer$349,485
R01 · FY2021 · CA · contact PI
Maximizing the delivery and efficacy of miRNA therapeutics through nanocarrier design$380,725
R35 · FY2020 · GM · contact PI
Multifunctional siRNA/antibody nanocarriers to treat metastatic triple-negative breast cancer$349,699
R01 · FY2020 · CA · contact PI
Maximizing the delivery and efficacy of miRNA therapeutics through nanocarrier design$380,995
R35 · FY2019 · GM · contact PI
Multifunctional siRNA/antibody nanocarriers to treat metastatic triple-negative breast cancer$349,907
R01 · FY2019 · CA · contact PI
Maximizing the delivery and efficacy of miRNA therapeutics through nanocarrier design$381,257
R35 · FY2018 · GM · contact PI
Maximizing the delivery and efficacy of miRNA therapeutics through nanocarrier design$63,006
R35 · FY2018 · GM · contact PI
Maximizing the delivery and efficacy of miRNA therapeutics through nanocarrier design$381,512
R35 · FY2017 · GM · contact PI
Maximizing the delivery and efficacy of miRNA therapeutics through nanocarrier design$381,759
R35 · FY2016 · GM · contact PI
Polyvalent siRNA-Gold Nanoparticle Constructs to Eradicate Glioma$47,543
F32 · FY2012 · CA · contact PI